At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

Vadodara: Sun Pharmaceutical Industries Limited's investee company, Lyndra Therapeutics Inc., has ceased operations due to ...

Sun Pharma made its investment choice in the company in December 2023. Back then, the company picked up stake 16.7 per cent ...

Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at the Massachusetts Institute of Technology in ...

Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

Lyndra Therapeutics, backed by Gates Foundation and Gilead, shuts down after failing to secure funding for Phase 3 safety ...

Immunovant gave investors a mixed set of news Wednesday, touting late-stage results for an experimental autoimmune disease drug while saying the company doesn’t currently plan to seek regulatory ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Arvinas lost more than half of its market value Tuesday morning after the Connecticut-based biotechnology company and partner Pfizer disclosed anticipated results from a late-stage clinical trial of a ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

Company to host a conference call and webcast today at 8:30 a.m. ET and will be joined by key opinion leader, Professor Jacky Smith Trevi Therapeutics, Inc. www.trevitherapeutics.com (PRNewsfoto ...